Clinical Trial Update: Moderately Hypofractionated Radiotherapy for Prostate Cancer. [NA]

View source ↗

Summary

An update on a clinical trial evaluating moderately hypofractionated radiotherapy for prostate cancer. The sponsor is Tatarstan Cancer Center and the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Tatarstan Cancer Center | Conditions: Prostatic Neoplasms, Genital Neoplasms | NA | Status: ACTIVE_NOT_RECRUITING